Tuberculosis in Paraguay: Epidemiological Characterization and Provisional Treatment Outcomes

Authors

DOI:

https://doi.org/10.66476/mf.v3n2.7416

Keywords:

tuberculosis, epidemiological monitoring, HIV coinfection, treatment outcome, Paraguay

Abstract

Introduction: Tuberculosis (TB) remains a public health problem in Paraguay. We aimed to describe case-finding indicators, the territorial distribution of notifications, treatment outcomes and diagnostic indicators of TB in Paraguay according to official 2026 records available in September 2026.

Materials and methods: Descriptive cross-sectional observational study based on aggregated secondary data from the Expert System of the National Tuberculosis Control Program (SEPNCT). Absolute and relative frequencies and cumulative notification rates per 100,000 population were calculated using National Institute of Statistics population projections. Treatment outcomes were considered provisional when the cohort had not been closed.

Results: A total of 27,771 presumptive TB cases were identified, of whom 88.0% were examined, and 3,289 TB cases were notified (national cumulative rate: 50.9 per 100,000). Notifications reached 53.8% of the annual programmatic target (6,111 cases). The highest notification rates were observed in Capital (238.3), Concepción (119.4) and Boquerón (95.1 per 100,000). In the published treatment cohort (n = 104; open cohort, treatment start period not specified), provisional treatment success was 58.7% (95% CI: 49.0–67.6), loss to follow-up 21.2% and death 9.6%; these values were not compared with the 90% target, which is defined for closed cohorts. The source reports treatment success percentages by subgroup without the number of patients, so they were not interpreted. There were 18,065 rapid molecular tests, 2,573 chest radiographs read with artificial intelligence support and 11 rifampicin-resistant/multidrug-resistant TB cases.

Conclusions: Records show heterogeneous notification across regions and provisional treatment outcomes estimated in a small, open cohort, which do not allow assessment of the international target or comparison across subgroups. The aggregated and provisional nature of the data does not allow causal inference; analyses of closed cohorts using individual-level data are needed.

Downloads

Download data is not yet available.

References

World Health Organization. Global tuberculosis report 2025. Geneva: WHO; 2025. Disponible en: https://www.who.int/publications/i/item/9789240116924

World Health Organization. The End TB Strategy. Geneva: WHO; 2015. Disponible en: https://www.who.int/publications/i/item/WHO-HTM-TB-2015.19

World Health Organization. Implementing the End TB Strategy: the essentials, 2022 update. Geneva: WHO; 2022. Disponible en: https://www.who.int/publications/i/item/9789240065093

Organización Panamericana de la Salud. The End TB Strategy: main indicators in the Americas [Internet]. Washington, D.C.: OPS; 2022 [citado 22 sep 2026]. Disponible en: https://www.paho.org/sites/default/files/2023-08/2022-cde-factsheet-end-tb-strategy.pdf

Ministerio de Salud Pública y Bienestar Social. Plan Estratégico de la Respuesta Nacional a la Tuberculosis en Paraguay 2016-2020 [Internet]. Asunción: MSPBS, Programa Nacional de Control de la Tuberculosis; 2016 [citado 20 oct 2026]. Disponible en: https://docs.bvsalud.org/biblioref/2021/08/1283290/plan_estrategico_nacional_tb.pdf

Medina A, Sussman J, Sosa N, Valdez M, Andrews JR, Croda J, et al. The concentration of tuberculosis within Paraguay's Indigenous population, 2018–2022: a retrospective population-based study. Lancet Reg Health Am. 2025;47:101140. https://doi.org/10.1016/j.lana.2025.101140

World Health Organization. WHO consolidated guidelines on tuberculosis: Module 6: tuberculosis and comorbidities. Geneva: WHO; 2024. Disponible en: https://www.who.int/publications/i/item/9789240087002

World Health Organization, International Union Against Tuberculosis and Lung Disease. Collaborative framework for care and control of tuberculosis and diabetes. Geneva: WHO; 2011. Disponible en: https://www.who.int/publications/i/item/9789241502252

Jeon CY, Murray MB. Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med. 2008;5(7):e152. https://doi.org/10.1371/journal.pmed.0050152

Baussano I, Williams BG, Nunn P, Beggiato M, Fedeli U, Scano F. Tuberculosis incidence in prisons: a systematic review. PLoS Med. 2010;7(12):e1000381. https://doi.org/10.1371/journal.pmed.1000381

Ministerio de Salud Pública y Bienestar Social, Dirección General de Vigilancia de la Salud, Programa Nacional de Control de la Tuberculosis. Plan Estratégico Nacional de Control de la Tuberculosis Multidrogo Resistente TB-MDR 2012-2015. Asunción: MSPBS; 2011. Disponible en: https://www.medbox.org/document/plan-estrategico-nacional-de-control-de-la-tuberculosis-multidrogo-resistente-tb-mdr-2012-2015

World Health Organization. WHO consolidated guidelines on tuberculosis. Module 3: diagnosis [Internet]. Geneva: WHO; 2025. Disponible en: https://www.who.int/publications/i/item/9789240107984

von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61(4):344-9. https://doi.org/10.1016/j.jclinepi.2007.11.008

Benchimol EI, Smeeth L, Guttmann A, Harron K, Moher D, Petersen I, et al. The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement. PLoS Med. 2015;12(10):e1001885. https://doi.org/10.1371/journal.pmed.1001885

Ministerio de Salud Pública y Bienestar Social, Programa Nacional de Control de la Tuberculosis. Datos estadísticos de Tuberculosis en Paraguay [tablero en Internet]. Asunción: MSPBS; 2026 [última actualización 22 sep 2026; citado 22 sep 2026]. Disponible en: https://datastudio.google.com/u/0/reporting/169b8665-dabd-45be-b048-b3500e85d78a/page/5eI0F

Ministerio de Salud Pública y Bienestar Social, Programa Nacional de Control de la Tuberculosis. Guía Nacional para el manejo de la Tuberculosis. 16.ª ed. Asunción: MSPBS; 2025 (aprobada por Resolución S.G. N.º 835 del 10 de noviembre de 2025) [citado 22 sep 2026]. Disponible en: https://dgvs.mspbs.gov.py/wp-content/uploads/2026/02/GUIA-NACIONAL-TB.-FINAL-2025.pdf

Ministerio de Salud Pública y Bienestar Social. Normas de procedimiento operativo de tuberculosis en centros penitenciarios del Paraguay (Resolución S.G. N.° 632/2016). Asunción: MSPBS; 2016. Disponible en: https://www.mspbs.gov.py/manuales-normativas.html

Ministerio de Salud Pública y Bienestar Social. Formulario 3: informe mensual de casos de TB y control de tratamiento. Asunción: MSPBS, Programa Nacional de Control de la Tuberculosis; 2019. Disponible en: https://dgvs.mspbs.gov.py/programa-nacional-de-control-de-la-tuberculosis/descargas-p-n-c-de-tuberculosis/

Ministerio de Salud Pública y Bienestar Social. Formulario 4: formulario de contactos y tratamiento de la infección tuberculosa latente o quimioprofilaxis. Asunción: MSPBS, Programa Nacional de Control de la Tuberculosis; 2019. Disponible en: https://dgvs.mspbs.gov.py/programa-nacional-de-control-de-la-tuberculosis/descargas-p-n-c-de-tuberculosis/

World Health Organization. Definitions and reporting framework for tuberculosis – 2013 revision (updated December 2014 and January 2020). Geneva: WHO; 2013. Disponible en: https://www.who.int/publications/i/item/9789241505345

Instituto Nacional de Estadística. Estimaciones y proyecciones departamentales, 2000-2035. Revisión 2025 [Internet]. Asunción: INE; 2025 [citado 22 sep 2026]. Disponible en: https://www.datos.gov.py/dataset/estimaciones-y-proyecciones-departamentales-2000-2035-revisi%C3%B3n-2025

Brown LD, Cai TT, DasGupta A. Interval estimation for a binomial proportion. Stat Sci. 2001;16(2):101-33. https://doi.org/10.1214/ss/1009213286

World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human participants. JAMA. 2025;333(1):71-4. https://doi.org/10.1001/jama.2024.21972

Consejo de Organizaciones Internacionales de las Ciencias Médicas (CIOMS), Organización Mundial de la Salud. Pautas éticas internacionales para la investigación relacionada con la salud con seres humanos. 4.ª ed. Ginebra: CIOMS; 2016. https://doi.org/10.56759/rgxl7405

Paraguay. Ley N.º 5282/14. De libre acceso ciudadano a la información pública y transparencia gubernamental. Asunción; 2014. Disponible en: https://www.bacn.gov.py/leyes-paraguayas/3013/libre-acceso-ciudadano-a-la-informacion-publica-y-transparencia-governamental

Dirección General de Vigilancia de la Salud. Informe de la vigilancia de tuberculosis, Paraguay, periodo 2018 [Internet]. Asunción: MSPBS; 2019 [citado 22 sep 2026]. Disponible en: https://dgvs.mspbs.gov.py/files/boletines_anuales/8_2018_BoletinAnual.pdf

Montiel I, Alarcón E, Aguirre S, Sequera G, Marín D. Factores asociados al resultado de tratamiento no exitoso de pacientes con tuberculosis sensible en Paraguay. Rev Panam Salud Publica. 2020;44:e89. https://doi.org/10.26633/RPSP.2020.89

World Health Organization. WHO consolidated guidelines on tuberculosis. Module 2: screening – systematic screening for tuberculosis disease. Geneva: WHO; 2021. Disponible en: https://www.who.int/publications/i/item/9789240022676

Dorman SE, Schumacher SG, Alland D, Nabeta P, Armstrong DT, King B, et al. Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study. Lancet Infect Dis. 2018;18(1):76-84. https://doi.org/10.1016/S1473-3099(17)30691-6

Qin ZZ, Ahmed S, Sarker MS, Paul K, Adel ASS, Naheyan T, et al. Tuberculosis detection from chest x-rays for triaging in a high tuberculosis-burden setting: an evaluation of five artificial intelligence algorithms. Lancet Digit Health. 2021;3(9):e543-54. https://doi.org/10.1016/S2589-7500(21)00116-3

Published

2026-10-26

Issue

Section

Artículos originales

How to Cite

Tuberculosis in Paraguay: Epidemiological Characterization and Provisional Treatment Outcomes. (2026). Revista De Medicina Familiar Y Comunidad, 3(2), 18–25. https://doi.org/10.66476/mf.v3n2.7416